Projects per year
Personal profile
Further information
Fingerprint
Dive into the research topics where Julia Slanovc is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
15d-PGJ2 und Osteosarkom: 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2): a plausible therapeutic agent against osteosarcoma?
Hrzenjak, A. (Principal investigator), Sattler, W. (Co-investigator), Mikulcic, M. (Co-investigator), Asslaber, M. (Co-investigator), Slanovc, J. (Co-investigator) & Bernhart, E. M. (Co-investigator)
1/10/18 → 31/10/21
Project: Research funding
-
RELEVANCE OF MicroRNAs IN CHEMOTHERAPY-RESISTANT HYPOXIC LUNG ADENOCARCINOMA
Hrzenjak, A. (Principal investigator), Klingseisen, V. (Co-investigator), Schein, S. (Co-investigator), Mack, M. (Co-investigator), Mikulcic, M. (Co-investigator), Panzitt, K. (Co-investigator), Slanovc, J. (Co-investigator), Seidl, C. (Co-investigator) & Birnstingl, A. (Co-investigator)
1/04/17 → 31/03/20
Project: Research funding
-
Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1.
Slanovc, J. (First author), Mikulcic, M., Jahn, N., Ghaffari Tabrizi-Wizsy, N., Sattler, W., Malle, E. & Hrzenjak, A. (Last author), Jan 2024, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1870, 1, p. 166924 13 p., 166924.Research output: Contribution to journal › Research article
3 Citations (Web of Science) -
Bisdemethoxycurcumin sensitizes the response of cisplatin resistant non-small cell lung carcinoma cell lines by activating apoptosis and autophagy
Klingseisen, V. (First author), Slanovc, J., Regouc, M. & Hrzenjak, A. (Last author), 2022, In: Journal of Nutritional Biochemistry.Research output: Contribution to journal › Research article
11 Citations (Web of Science) -
Prostaglandin 15d-PGJ2 is a potent compound for treatment of lung adenocarcinoma
Slanovc, J., Mikulcic, M., Jahn, N., Ghaffari Tabrizi-Wizsy, N. & Hrzenjak, A., 2022, In: Wiener Klinische Wochenschrift.Research output: Contribution to journal › Conference abstract
Activities
- 1 Poster
-
Prostaglandin 15d-PGJ2 is a potent compound for treatment of lung adenocarcinoma
Slanovc, J. (Author), Mikulcic, M. (Author), Jahn, N. (Author), Ghaffari Tabrizi-Wizsy, N. (Author) & Hrzenjak, A. (Author)
2022Activity: Talk, presentation or poster › Poster
Thesis
-
Influence of prostaglandin 15d-PGJ2 on lung adenocarcinoma cells.
Slanovc, J. (Author), Hrzenjak, A. (Supervisor), 2021Student thesis